[1]
2024. Effect of Spesolimab on Achieving Sustained Disease Remission in Patients with Generalized Pustular Psoriasis: Results from the Effisayil 2 Study. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s357. DOI:https://doi.org/10.25251/skin.8.supp.357.